GLOW Peptide Blend

GHK-Cu • BPC-157 • TB-500

What Is GLOW?

GLOW is a physician-guided peptide therapy that combines three complementary, research-backed peptides into a single protocol: GHK-Cu, BPC-157, and TB-500. Each peptide targets a different piece of how the body repairs and renews itself, which is why the blend is used to support skin quality, tissue recovery, and overall wellness at the same time — rather than addressing just one of those goals in isolation.

The three components of the blend are:

GHK-Cu (copper peptide): a naturally occurring, copper-binding peptide that the body produces on its own, but at declining levels with age. It is closely tied to collagen and elastin production and is widely used in regenerative and dermatologic settings to support skin firmness, tone, and texture.
BPC-157: a peptide studied for its role in supporting blood vessel formation and tissue repair at sites of injury, and commonly discussed for gut, tendon, and ligament wellness.
TB-500: a thymosin-beta-4–derived peptide that supports the movement of repair cells to the tissues that need them, contributing to flexibility, mobility, and recovery.

GLOW is compounded and administered under physician supervision as part of an individualized wellness plan. It is not FDA-approved as a drug product, and — like other compounded peptide therapies — it is intended for use only under the guidance of a licensed provider who has evaluated your health history and goals.

Potential Benefits

Patients pursuing GLOW therapy typically do so as part of a broader recovery, aesthetic, or healthy-aging plan. Reported and researched benefits associated with the three peptides in this blend include:

Support for collagen and elastin production, contributing to firmer, more elastic-looking skin
Improved skin tone, texture, and overall appearance
Support for connective tissue repair, including tendons and ligaments
Faster recovery from exercise, minor injury, or physical strain
Support for healthy inflammatory response
Support for gut lining integrity and digestive comfort
Improved mobility and flexibility
General support for a whole-body healthy-aging and recovery routine

Individual results vary based on health history, goals, and adherence to the prescribed protocol. Your provider will discuss which benefits are realistic for your specific situation.

Dosing Overview

GLOW is administered as a daily subcutaneous injection on a 5-days-on, 2-days-off schedule, typically for a defined cycle followed by a rest period before any additional cycle is considered. Below is a general overview of how this protocol is commonly structured in clinical practice. Your prescribing provider will confirm your exact dose, concentration, and schedule based on your compounded formulation and individual evaluation — the figures below are a general reference, not a personal prescription.

Route	Subcutaneous (SubQ) injection
Typical dose	0.33 mL (33 units on a U-100 insulin syringe)
Schedule	5 days on, 2 days off — repeated for the length of the cycle
Frequency	Once daily on “on” days, at approximately the same time each day
Typical cycle length	4–6 weeks, followed by a 2–4 week rest period
Common blend ratio	5:1:1 (GHK-Cu : TB-500 : BPC-157)
Storage (unmixed)	Keep lyophilized (powder) vials frozen or refrigerated as directed
Storage (reconstituted)	Refrigerate; use within the timeframe your provider specifies (commonly 3–4 weeks)
Injection sites	Rotate sites (abdomen, thigh) to reduce irritation, as instructed by your provider

Administration Reminders

Use only the exact dose and reconstitution instructions provided by your prescribing physician or clinical team — these are specific to your compounded vial.
Never adjust your dose, frequency, or cycle length without speaking to your provider first.
Use a new, sterile syringe for every injection and dispose of sharps properly.
Store all peptides exactly as instructed to preserve potency and safety.
Contact the clinic promptly if you notice unexpected redness, swelling, or other side effects at the injection site, or any symptoms that concern you.

IMPORTANT SAFETY INFORMATION GLOW peptide therapy (GHK-Cu, BPC-157, TB-500) is a compounded, physician-supervised treatment. These peptides are not approved by the FDA as drug products, and this document is provided for general patient education only — it is not a substitute for individualized medical advice. Dosing must always be determined by your prescribing physician based on your health history, current medications, and treatment goals. Do not begin, stop, or adjust this therapy without direct guidance from your Colorado Slim provider

Questions about GLOW?

Ask your Colorado Slim provider at your next visit.